Evidence map›Paper›PMID 19300439›Full record

ArticleThe EMBO journal2009

Acid sphingomyelinase activity triggers microparticle release from glial cells.

Fabio Bianco, Cristiana Perrotta, Luisa Novellino, Maura Francolini, Loredana Riganti, Elisabetta Menna, Laura Saglietti, Edward H Schuchman, Roberto Furlan, Emilio Clementi and 2 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 361 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
361citing papers in PubMed, 1 pooled it
14.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

361 citing papers in PubMed, 1 synthesis or guideline pooled it, 577 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review

301 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Fabio BiancoCNR Institute of Neuroscience and Department of Medical Pharmacology, University of Milano, Milano, Italy.
Cristiana Perrotta
Luisa Novellino
Maura Francolini
Loredana Riganti
Elisabetta Menna
Laura Saglietti
Edward H Schuchman
Roberto Furlan
Emilio Clementi
Michela Matteoli
Claudia Verderio
University of Milan · ITDon Carlo Gnocchi Foundation · ITIcahn School of Medicine at Mount Sinai · USIRCCS Eugenio Medea · ITLuigi Sacco Hospital · ITNeuro-Zone (Italy) · ITVita-Salute San Raffaele University · IT

Funding

ACID SPHINGOMYELINASE & NIEMANN-PICK DISEASER01HD028607 · NICHD · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI SCHUCHMAN, EDWARD H. · 1992 to 2011
$4.4M
NICHD NIH HHS R01 HD028607NICHD NIH HHS R01HD28607
6 · The paper itself

Abstract

We have earlier shown that microglia, the immune cells of the CNS, release microparticles from cell plasma membrane after ATP stimulation. These vesicles contain and release IL-1beta, a crucial cytokine in CNS inflammatory events. In this study, we show that microparticles are also released by astrocytes and we get insights into the mechanism of their shedding. We show that, on activation of the ATP receptor P2X7, microparticle shedding is associated with rapid activation of acid sphingomyelinase, which moves to plasma membrane outer leaflet. ATP-induced shedding and IL-1beta release are markedly reduced by the inhibition of acid sphingomyelinase, and completely blocked in glial cultures from acid sphingomyelinase knockout mice. We also show that p38 MAPK cascade is relevant for the whole process, as specific kinase inhibitors strongly reduce acid sphingomyelinase activation, microparticle shedding and IL-1beta release. Our results represent the first demonstration that activation of acid sphingomyelinase is necessary and sufficient for microparticle release from glial cells and define key molecular effectors of microparticle formation and IL-1beta release, thus, opening new strategies for the treatment of neuroinflammatory diseases.

Indexed as

Adenosine TriphosphateAdrenergic Uptake InhibitorsAffinity LabelsAnimalsBrainCell-Derived MicroparticlesCells, CulturedEnzyme ActivationImipramineInterleukin-1betaMiceMice, KnockoutModels, BiologicalNeurogliap38 Mitogen-Activated Protein KinasesParticle Size3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphateAdenosine TriphosphateAdrenergic Uptake InhibitorsAffinity LabelsImipramineInterleukin-1betaP2rx7 protein, mousep38 Mitogen-Activated Protein KinasesReceptors, Purinergic P2Receptors, Purinergic P2X7Sphingomyelin Phosphodiesterasesrc-Family Kinases

Identifiers

PMID19300439
PMCPMC2664656
OpenAlexW2041890590

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.